Capital Firm Updates
Cleveland Clinic Innovations
Cleveland Clinic launched its office of business development to grow its innovation efforts and embark on a new digital transformation strategy. In its first quarter financial report , it outlined changes it made in the last … more than $10 million in investments in 10 companies. Overall, Cleveland Clinic Innovations and Cleveland Clinic Ventures have formed 92 spinoffs and monetized 23. Cleveland Clinic Innovations has over 1,650 issued patents.Cleveland Clinic’s Office of …
Bill & Melinda Gates Foundation
Egan: Bill Gates is the most interesting man in the world | 5/25/2020
… without borders, Gates has filled the void. The U.S. is isolated, pitied, scorned. Gates, by one measure, is the most admired man in the world. Beyond the $300 million that the Bill and Melinda Gates Foundation has given to blunt the spread of the virus, Gates has made himself a spokesman for science. It needs one. While President Donald Trump spouts life-threatening nonsense, Gates calmly explains how a spike …
SunTrust Bank
Argent Trust Co Acquires 1,672 Shares of CVS Health Corp (NYSE:CVS) | 5/23/2020
… SunTrust Banks decreased their price target on shares of CVS Health from $90.00 to $80.00 and set a “buy” rating for the company in a report on Monday, April 13th. Robert W. Baird upped their price objective on shares of CVS Health from $62.00 to $66.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. UBS Group cut their price objective on shares of …
William Blair
Labs welcome CMS rate for coronavirus antibody testing May 21, 2020 Dive Brief: CMS set the reimbursement rate for Medicare Administrative Contractors covering the main type of coronavirus antibody test at approximately $42, per an update Tuesday. That rate exceeds investment firm William Blair’s $25 estimate for the category of tests, boding well for future reimbursement policy for antigen testing, analysts noted. Last month, the agency doubled its reimbursement for …
Apple Tree Partners
Boulder Care opioid treatment platform picks up traction during coronavirus | 5/21/2020
Jordan Crook @jordanrcrook / 22 hours With the regulations around telehealth changing rapidly during the COVID-19 pandemic, an opioid treatment platform with a digital component is finally finding a strong market foothold after facing a mountain of regulatory hurdles. Boulder Care was founded by Stephanie Papes, a former associate at Apple Tree Partners. She first became interested in opioid treatment after facilitating the firm’s financing round with an organization called …
Healthbox
… Healthbox. “It’s an emphasis on the haves and have-nots of healthcare providers,” said Gernot speaking during a recent virtual media event sponsored by the Healthcare Information and Management Systems Society (HIMSS) on the impact of the pandemic on the future of healthcare. “The organizations that had a tight digital strategy, that were good at telehealth, had money in the bank, by and large, those healthcare systems, unless they are …
Smith & Nephew
… Smith & Nephew Plc, Supermax Corp. Berhad, Thermo Fisher Scientific Inc., and Top Glove Corp. Bhd are some of the major market participants. The rapid spread of COVID-19 will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Rapid spread of COVID-19 has been …
Daiichi Sankyo
WILMINGTON, Del.–(BUSINESS WIRE)–May 18, 2020– AstraZeneca and Daiichi Sankyo Company, Limited’s (Daiichi Sankyo) ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a HER2 mutation and with disease progression on or after platinum-based therapy. NSCLC is the most common type of lung cancer, and prognosis …
Merrill Lynch
Edited Transcript of ATR earnings conference call or presentation 1-May-20 1:00pm GMT | 5/17/2020
… Merrill Lynch, Research Division - MD and Co-Sector Head in Equity Research Ghansham Panjabi Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst Neel Kumar Morgan Stanley, Research Division - Equity Analyst Presentation Operator [1] Ladies and gentlemen, thank you for standing by, and welcome to AptarGroup 2020 First Quarter Conference Call. (Operator Instructions) Introducing today’s conference call is Mr. Matt DellaMaria, Senior Vice President, Investor Relations and Communications. Please …
Citigroup
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios | 5/16/2020
… Goldman Sachs, Cooperman bought JPMorgan and sold Citigroup and Wells Fargo, Buffett sold Goldman Sachs, and Soros sold Bank of America, Citigroup, JPMorgan and Wells Fargo. Several fund managers traded ETFs to play particular themes. Rosenstein and Smith sold the SPY ETF, while Soros bought municipal bond and investment-grade corporate bond ETFs.Here’s a rundown of how the smart money was playing some of the most popular stocks last quarter.See …
JP Morgan
… Goldman Sachs Group Inc., Research Division - Equity Analyst Gabor Zoltan Kemeny Autonomous Research LLP - Research Analyst Johannes Thormann HSBC, Research Division - Global Head of Exchanges and Analyst Máté Nemes UBS Investment Bank, Research Division - Associate Director and Analyst - European Banks Research Riccardo Rovere Mediobanca - Banca di credito finanziario S.p.A., Research Division - Research Analyst Samuel Magnum Goodacre JP Morgan Chase & Co, Research Division - Executive Director and Head of Emerging Market Europe …
JP Morgan Chase
… Goldman Sachs Group Inc., Research Division - Equity Analyst Gabor Zoltan Kemeny Autonomous Research LLP - Research Analyst Johannes Thormann HSBC, Research Division - Global Head of Exchanges and Analyst Máté Nemes UBS Investment Bank, Research Division - Associate Director and Analyst - European Banks Research Riccardo Rovere Mediobanca - Banca di credito finanziario S.p.A., Research Division - Research Analyst Samuel Magnum Goodacre JP Morgan Chase & Co, Research Division - Executive Director and Head of Emerging Market Europe …
BlackRock
BlackRock Completes Secondary Offering of Common Stock - Business Wire | 5/15/2020
BlackRock Completes Secondary Offering of Common Stock May 15, 2020 04:00 PM Eastern Daylight Time NEW YORK–( BUSINESS WIRE )–BlackRock, Inc. (the “Company”) (NYSE:BLK) today announced that it has completed the secondary offering of … and internationally through underwriters led by joint book-running managers, Morgan Stanley, Citi and Evercore ISI. In connection with the PNC disposition, William S. Demchak has resigned from BlackRock’s board of directors. BlackRock has filed …
Clearlake Capital Group
LINDA BUAN NAMED PROVATION’S CTO May 15, 2020 09:05 ET Source: Provation Daniel Hamburger, CEO Linda Buan, CTO Minneapolis, MN, May 15, Minneapolis, MN and Santa Monica, CA – May 15th, 2020 – Provation, the premier software provider of procedure documentation and clinical decision support solutions, backed by Clearlake Capital Group, L.P., today announced that Linda Buan, previously Vice President, Product Develop and Operations at Provation, has been promoted to Chief Technology …
General Atlantic
The Funded: 10 Bay Area startups score $170M at week’s end | 5/15/2020
… Qualcomm Ventures, AMD Ventures and Navitas Capital. Quizlet Inc., San Francisco, $30 million: General Atlantic led the Series C funding of this developer of a flash cards platform . The business was valued at $1 billion in the round. Read more here. Envoy Inc., San Francisco, $30 million: This workplace management platform maker raised funding from TriplePoint Capital. Clear Labs Inc., San Carlos, $18 million: Redmile Group led the investment in …
Lux Capital
The Funded: 10 Bay Area startups score $170M at week’s end | 5/15/2020
Ten Bay Area startups disclosed about $170 million in new funding at the end of the week. Here are the details. Funding Matterport Inc., Sunnyvale, $40 million: The provider of 3D capture software disclosed its new funding in an SEC filing that doesn’t say who participated. It previously raised over $100 million from investors who include DCM, Lux Capital, Red Swan Ventures, Qualcomm Ventures, AMD Ventures and Navitas Capital. Quizlet …
Khosla Ventures
… Khosla Ventures, GV, Felicis Ventures, and HBM Genomics. To date, Clear Labs has raised $62M. In addition to supporting ongoing commercialization of the company’s food safety platform, Clear Safety, the funds will be used to leverage the company’s underlying Next Generation Sequencing (NGS) technology in the clinical market, specifically to enhance the availability and quality of COVID-19 diagnostic tests. Experts agree that the limitations of COVID-19 testing have …
EcoR1 Capital
… EcoR1 Capital, Eventide Asset Management, RA Capital Management, and Samsara BioCapital, among others. The shares were offered by Sutro pursuant to a registration statement on Form S-3 previously filed and declared effective by the Securities and Exchange Commission (SEC). A final prospectus supplement and the accompanying prospectus relating to this offering have been filed with the SEC. Copies of the final prospectus supplement may be obtained from: Cowen and …
Menlo Ventures
… Menlo Ventures, Tyson Ventures, Khosla Ventures, GV, Felicis Ventures, and HBM Genomics. To date, Clear Labs has raised $62M. In addition to supporting ongoing commercialization of the company’s food safety platform, Clear Safety, the funds will be used to leverage the company’s underlying Next Generation Sequencing (NGS) technology in the clinical market, specifically to enhance the availability and quality of COVID-19 diagnostic tests. Experts agree that the limitations of …
Cowen and Company
SOUTH SAN FRANCISCO, Calif. , May 14, Sutro Biopharma, Inc. (Nasdaq: STRO ), a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF®, to create a … Copies of the final prospectus supplement may be obtained from: Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Attn: Prospectus Department, by telephone at (833) 297-2926 …
Citigroup Global Markets
… not limited to, repurchases of our common stock), dividends and satisfaction of other obligations. Goldman Sachs & Co. LLC, J.P. Morgan, Citigroup and Evercore acted as representatives of the underwriters and joint book-running managers for … York 11717, Telephone: (866) 803-9204, Email: [email protected] ; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Telephone: 1-800-831-9146; and Evercore Group L.L.C., Attention: Equity …
Imperial Capital
… Morgan Stanley, Research Division - MD David Walter Miller Imperial Capital, LLC, Research Division - Research Analyst Eric Owen Handler MKM Partners LLC, Research Division - MD, Sector Head & Senior Analyst Stephan Edward Bisson Wolfe Research, LLC - Research Analyst Presentation Operator [1] Excuse me, everyone. We now have Sean Reilly and Jay Johnson in conference. (Operator Instructions) In the course of this discussion, Lamar may make forward-looking statements regarding the company, including …
Blackstone Group
… TeamHealth, a physician practice and staffing company that provides the hospital with emergency room services. TeamHealth is owned by Blackstone Group, a finance giant. When a private staffing firm teams up with a hospital, the right to due process can disappear. Lin’s case was never heard. “One of the objectives is to point out any deficiencies in the system that may harm the patient,” Lin told NBC News. “Because private …
Warburg Pincus
… was TeamHealth, a physician practice and staffing company that provides the hospital with emergency room services. TeamHealth is owned by Blackstone Group, a finance giant. When a private staffing firm teams up with a hospital … Blackstone, Apollo Global Management, The Carlyle Group, KKR & Co. and Warburg Pincus have deployed more than $340 billion to buy health care-related operations around the world. In 2019, private equity’s health care acquisitions reached …
RBC Capital Markets
… RBC Capital Markets, Research Division - Director, Co-Head of European Energy Research Team & Lead Analyst Irene Himona Societe Generale Cross Asset Research - Equity Analyst Lydia Rose Emma Rainforth Barclays Bank PLC, Research Division - Director & Equity Analyst Matthew Peter Charles Lofting JP Morgan Chase & Co, Research Division - VP Mehdi Ennebati BofA Merrill Lynch, Research Division - Research Analyst Michele Della Vigna Goldman Sachs Group Inc., Research Division - Co-Head of European Equity …
